Syra Health Corp (SYRA) Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
Sector: Services-Employment Agencies
Industry: Medical - Care Facilities
Syra Health Corp. Class A Common Stock OTC:SYRA Healthcare · Medical - Care Facilities
Mkt Cap $8.11M
EV -
SI 7.6%
Net Cash/Sh -
Earnings Nov 18 · Today
CLOSED Prev close $0.7192 -20.59%Close $0.5711 VOL 202K $ Vol $113K RVOL 5.49x
Mkt Cap $8.11M
EV -
VOL 202K sh
$ Vol $113K
RVOL 5.49×
SI 7.6%
Net Cash/Sh -
Earnings Nov 18 · Today
Press Release ● Major
Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin
Syra Health reported its third consecutive profitable quarter, with record Q3 2026 revenue of $2.6 million, up 52% year-over-year. Gross margin hit a company-record 46.3%, up 1,340 basis points, while EPS swung to $0.02 from a $(0.02) loss and EBITDA turned positive at $301,725. Nine-month operating cash flow reached $975,023 and cash sits at $2.4 million with no long-term debt; the company remains on track for full-year 2026 profitability.
• 14d ago AI analysis › Press Release
Syra Health To Announce Third Quarter 2026 Financial Results
Syra Health announced it will report Q3 2026 financial results on Tuesday, November 3, 2026, via press release before market open.
• 21d ago AI analysis › Press Release
Syra Health Awarded Three-Year Public Health Analytics Contract with Mississippi State Department of Health
Syra Health was awarded a three-year contract from the Mississippi State Department of Health to provide epidemiology, evaluation, and biostatistics services. The contract runs from September 2, 2026 through September 1, 2029 with a not-to-exceed value of $240,000, and MSDH may renew for two additional one-year periods.
• 1mo ago AI analysis › Press Release
Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy
Syra Health, in partnership with HealthSync, has been accepted into the CMS ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model, a federal program aimed at improving chronic-care delivery and value-based reimbursement. Under the collaboration, the two companies will engage providers and support patient referrals into ACCESS-aligned programs using Syra Health's digital behavioral health platform Syrenity, targeting individuals enrolled in Original Medicare. The HealthSync partnership remains subject to negotiation and execution of a definitive agreement, and no financial terms were disclosed.
• 2mo ago AI analysis › Press Release
Syra Health, Wake County Public Health Expand Wellness Partnership
Syra Health expanded its partnership with Wake County Public Health, launching the Wellness S.P.A. 2.0 program following a successful pilot. The program focuses on employee mental health and resilience through six-week cohorts, with additional rounds planned later this year and early in 2027.
• 2mo ago AI analysis › Press Release
Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
Syra Health reported its second consecutive profitable quarter with Q2 revenue of $2.4 million, up 23% year-over-year, and net income of $250,242 compared to a net loss in the prior year. Gross margin expanded significantly to 44.5% from 38.7% last year, while EBITDA turned positive to $253,200.
• 3mo ago AI analysis › Press Release
Syra Health To Announce Second Quarter 2026 Financial Results
Syra Health announced it will report its second quarter 2026 financial results on Tuesday, August 11, 2026. The press release with results will be issued before the market opens.
• 3mo ago AI analysis › Press Release
Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy
Syra Health appointed Dr. Cori McMahon as Chief Medical Officer in a fractional capacity to support its growth strategy and strengthen stakeholder engagement. Dr. McMahon is a licensed behavioral medicine psychologist currently at Cooper University Health Care and will provide clinical guidance for the company's behavioral and population health solutions.
• 4mo ago AI analysis › Press Release ● Major
Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position
Syra Health reported its first profitable quarter in Q1 2026, with net income of approximately $241,000 swinging from a loss in the prior year. Total revenue grew 22% year-over-year to $2.3 million, driven by a 46% increase in population health solutions revenue to $1.8 million.
• 6mo ago AI analysis › Press Release ● Major
Syra Health To Announce First Quarter 2026 Financial Results
prnewswire.com • 6mo ago Press Release
Syra Health Wins Innovation of the Year and BioCrossroads Life Sciences Innovation Award at the 2026 TechPoint Mira Awards
Syra Health won two 2026 Mira Awards, securing the BioCrossroads Life Sciences Innovation Award for its Syrenity behavioral health platform and the overall Innovation of the Year honor for its AI-driven tools including SyraBot. The awards, presented by TechPoint and selected from 231 submissions, validate the company's technology-enabled approach to care coordination and population health.
• 6mo ago AI analysis ›